Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Pricing: market research reports

1594

Pricing is a challenging area for life science products, be they drug therapies, devices or a new test product. In all industries products are priced to account for market conditions and cost. In healthcare pricing has to be considered in many cases along with reimbursement rates of standard treatments, the economic conditions and healthcare funding in many countries.

Pricing for pharmaceutical products requires a long-term approach.

A pricing strategy may be valid given cost and market conditions, but when considers that the earning period of a given therapy may be a decade, this must be accounted for in pricing. Market conditions will also be a factor, in pharmaceuticals, a company must consider the role generics play after patent expiration, generic threats may be present. Some companies have reacted to generic threats with underpricing strategy to reduce the impact of the threat.

RSS Feeds

Pricing market research reports and industry analysis

< prev 1  2  3  4  5  6  7  next >
US Pharmaceutical Industry – PEST Framework Analysis
11/1/2012 | published by: Aruvian's R'search
... solutions. The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market. The US continues to generate the ...  |  more...
$200.00
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
11/1/2012 | published by: Aruvian's R'search
... The process of “drug discovery/invention” is elaborate requiring on an average 8-10 years at a cost of US$ 300 million to reach a new drug to the market. Aruvian's R'search analyzes the Pharmaceutical Industry in ...  |  more...
$200.00
Key Findings: Brazil Pharmaceutical Market Overview
9/27/2012 | published by: Business Insights
... slowing sales growth in more developed markets. Features and benefits Analysis of population demographics, economic wealth, disease burden, level of industrialization, and political structure in Brazil. Insight into the healthcare system, drug regulation, drug pricing, ...  |  more...
$1,910.00
Global Healthcare Policy Analysis 2012 – Regulatory, Pricing, and Reimbursement Assessment
8/27/2012 | published by: GlobalData
... pharmaceutical markets around the world. Focusing on the global regulatory landscape in 2012, the report integrates in-depth research into the policies of major international markets with expert insight to reveal the opportunities and threats that ...  |  more...
$2,995.00
Pharmaceutical Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins
8/6/2012 | published by: GBI Research
... Supply Chain in Japan - Periodic Drug Price Revisions by National Health Insurance Increase Competition and Squeeze Profit Margins”. The report focuses on the current scenario of supply chain management. Key participants in the pharmaceutical ...  |  more...
$3,500.00
Healthcare, Regulatory and Reimbursement Landscape - Australia
7/24/2012 | published by: GlobalData
... on the healthcare, regulatory and reimbursement landscape in Australia. It identifies key trends, and most importantly, provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using ...  |  more...
$1,995.00
Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
7/10/2012 | published by: GBI Research
... Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity” provides detailed insight into the Europe API market. ...  |  more...
$3,500.00
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7/10/2012 | published by: GBI Research
... “Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities”. It provides a comprehensive overview of the healthcare system, and the pricing and reimbursement ...  |  more...
$3,500.00
Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing
7/10/2012 | published by: GBI Research
... Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing”. The report focuses on the current scenario of supply chain management. Key participants in the pharmaceutical supply chain ...  |  more...
$3,500.00
Healthcare, Regulatory and Reimbursement Landscape - South Korea
6/30/2012 | published by: GlobalData
... and an analysis on the healthcare, regulatory and reimbursement landscape of South Korea. The report identifies the key trends in the healthcare market of South Korea. The report also provides insights on the demographic, regulatory, ...  |  more...
$1,995.00
Variations in Regional Supplier Prices in the Pharmaceutical Industry - 2012–2013 : Survey Snapshot
6/28/2012 | published by: iCD Research
... ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how variations in regional supplier practices are set to change in the pharmaceutical industry in 2012–13. The report also provides access to information categorized ...  |  more...
$325.00
The Pharmaceutical Market in Saudi Arabia
6/22/2012 | published by: Business Insights
... detail. The report also provides profiles of the leading companies, incorporating their product portfolios and growth strategies in Saudi Arabia. Features and benefits Plan your company's strategy for Saudi Arabia by assessing factors driving and ...  |  more...
$2,875.00
The Pharmaceutical Market in Israel
6/22/2012 | published by: Business Insights
... are also analyzed. Features and benefits Plan your company's strategy for Israel by assessing factors driving and restraining market growth. Forecast the growth of patented and generic markets to 2017. Understand Israel's health insurance and ...  |  more...
$2,875.00
Emerging Pharmaceutical Markets in the Middle East
6/22/2012 | published by: Business Insights
... An attractiveness index allowing comparison of the five countries along four dimensions is also presented. Features and benefits Forecast pharmaceutical sales for five key Middle East countries to 2017. Gain insights into the relative merits ...  |  more...
$4,795.00
The Pharmaceutical Market in Egypt
6/22/2012 | published by: Business Insights
... and counterfeits. It examines pharmaceutical sales, manufacturing, trade, and major multinationals and local companies. Features and benefits Understand the key pharmaceutical market characteristics, including total market size, growth drivers and resistors and overall market attractiveness. ...  |  more...
$2,875.00
Healthcare, Regulatory and Reimbursement Landscape Russia
6/18/2012 | published by: GlobalData
... on the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides ...  |  more...
$1,995.00
Healthcare, Regulatory and Reimbursement Landscape Vietnam
6/18/2012 | published by: GlobalData
... on the healthcare, regulatory and reimbursement landscape of Vietnam. It identifies the key trends in the healthcare market of Vietnam and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of the country. ...  |  more...
$1,995.00
Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures
6/12/2012 | published by: GBI Research
... in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures”. The report provides a comprehensive overview of the healthcare system, and pricing and reimbursement process in China with key data, information ...  |  more...
$3,500.00
Emerging Pharmaceutical Market in Indonesia and Philippines - 100% Foreign Direct Investment in Indonesia and Extensive Insurance Coverage in the Philippines Attract Foreign Pharma Companies
6/4/2012 | published by: GBI Research
... and Philippines - 100% Foreign Direct Investment in Indonesia and Extensive Insurance Coverage in the Philippines Attract Foreign Pharma Companies”, provides an in-depth analysis of trends, issues and challenges in the pharmaceutical market in Indonesia ...  |  more...
$3,500.00
Healthcare, Regulatory and Reimbursement Landscape - Indonesia
5/21/2012 | published by: GlobalData
... and identifies the key trends in Indonesia’s healthcare market. It also provides an insight into the demographic, regulatory, and reimbursement landscape, and the overall healthcare infrastructure. Most importantly, the report provides valuable insights into the ...  |  more...
$1,995.00
Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs
5/18/2012 | published by: GBI Research
... Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs”. It provides a comprehensive overview of the healthcare system, and pricing and reimbursement process in Brazil with ...  |  more...
$3,500.00
Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs
5/18/2012 | published by: GBI Research
... released its latest research “Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs”. It provides a comprehensive overview ...  |  more...
$3,500.00
The Pharmaceutical Market: Poland
5/15/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  more...
$1,085.00
The Pharmaceutical Market: Japan
5/15/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  more...
$1,085.00
The Pharmaceutical Market: Germany
5/14/2012 | published by: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...  |  more...
$1,085.00
< prev 1  2  3  4  5  6  7  next >